Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2021

Feb 14, 2022

BUY
$50.01 - $73.35 $160,032 - $234,719
3,200 Added 41.56%
10,900 $610,000
Q3 2021

Nov 15, 2021

SELL
$59.21 - $78.66 $230,919 - $306,774
-3,900 Reduced 33.62%
7,700 $501,000
Q2 2021

Aug 16, 2021

SELL
$51.39 - $66.9 $282,645 - $367,950
-5,500 Reduced 32.16%
11,600 $736,000
Q1 2021

May 17, 2021

BUY
$49.14 - $59.89 $840,294 - $1.02 Million
17,100 New
17,100 $1.02 Million

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.